Evermay Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Evermay Wealth Management's VRTX Position: Q2 2026 in Review
Evermay Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 234% in Q2 2026, buying an estimated $33.2K and bringing the position to 107 shares worth $53.2K. The position accounts for 0.01% of the portfolio, ranked #350.
Evermay Wealth Management first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $143K in Q2 2024. 1,760 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Evermay Wealth Management held 107 shares of Vertex Pharmaceuticals worth $53.2K as of Q2 2026.
- Evermay Wealth Management bought 75 Vertex Pharmaceuticals shares in Q2 2026, an estimated $33.2K.
- Vertex Pharmaceuticals made up 0.01% of Evermay Wealth Management's portfolio in Q2 2026, its #350 holding.
- Evermay Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
- Evermay Wealth Management's Vertex Pharmaceuticals position peaked at $143K in Q2 2024.
- 1,760 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.